EBITDA is expected to be in the range of $1.4B to $1.5B. This is an upgrade to the previous guidance and 25% to 30% increase on the previous year. To me, this seems pretty good. Where analyst expectations higher?
Then again, expenses - like share-based compensation - just keep climbing.
Ann: Form 8-K Current Report, Items 2.02 and 9.01, page-3
Add SQ2 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$113.81 |
Change
-3.270(2.79%) |
Mkt cap ! $4.326B | |||
| Open | High | Low | Value | Volume |
| $112.46 | $113.88 | $112.27 | $58.35M | 524.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 527 | $113.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $113.88 | 738 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$113.71 |
Change
-3.270 ( 2.82 %) |
||||
| Open | High | Low | Volume | ||
| $112.48 | $113.88 | $112.27 | 3981 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| SQ2 (ASX) Chart |